News
2017
company
year
domain
Syros Announces Appointment of Jeremy P. Springhorn as Chief Business Officer
Syros Pharmaceuticals 11.13.2017
Syros Receives FDA Orphan Drug Designation for SY-1425 for Treatment of AML
Syros Pharmaceuticals 08.21.2017